ViraTherapeutics' Acquisition

ViraTherapeutics was acquired by Boehringer Ingelheim on September 13, 2018.

ViraTherapeutics is a biopharmaceutical company developing virus-based immunotherapeutics for the treatment of cancer. ViraTherapeutics develops oncolytic cancer vaccines based on chimeric virus deriv…

Articles about ViraTherapeutics' Acquisition: